FORMULARY DECISION
Etanercept : Enbrel
TA383 (SMC 212/05) : For the treatment of severe active ankylosing spondylitis.
We have found 20 results when searching "Etanercept"
TA383 (SMC 212/05) : For the treatment of severe active ankylosing spondylitis.
TA383 (SMC 303/06) : For the treatment of ankylosing spondylitis.
TA199 (SMC 304/06) : Psoriatic arthritis
TA375 (SMC 305/06) : Rheumatoid Arthritis
TA455 (SMC 570/09) : Chronic severe plaque psoriasis in children and adolescents
TA455 (SMC 781/12) : For the treatment of chronic severe plaque psoriasis in children and adolescents from the age of 6 years who are inadequately controlled by, or are intolerant to, other systemic t...
TA373 (SMC 782/12) : For the treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have pro...
842/13 : For the treatment of polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in children and adolescents
TA103 : For treating severe psoriasis in adults.
Immunosuppressant therapy for islet cell transplant